# US 2019/0316115 A1 · Methods and apparatuses for gene purification and imaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316115 A1
- Document ID: US20190316115A1
- Status: Published application
- Kind: A1
- Application number: 16/272,073
- Filed: 2019-02-11
- Published: 2019-10-17
- Earliest claimed: 2014-11-24
- Assignees: NanoString Technologies, Inc.
- Applicants: NanoString Technologies, Inc.
- Inventors: Dwayne Dunaway; Rustem Khafizov; Qian Mei; Lucas Dennis; Michael Krouse; Joseph M. Beechem; Isaac Sprague
- Web page: https://patentgrep.com/patent/US20190316115A1

## CPC

- C12N 15/1013: {by using magnetic beads}
- B01L 3/502723: {characterised by venting arrangements}
- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6825: Nucleic acid detection involving sensors
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- B01L 2200/0631: Purification arrangements, e.g. solid phase extraction [SPE]
- B01L 2200/0668: Trapping microscopic beads
- B01L 2200/10: Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
- B01L 2300/0627: Sensor or part of a sensor is integrated
- B01L 2300/0867: Multiple inlets and one sample wells, e.g. mixing, dilution
- B01L 2300/0887: Laminated structure
- B01L 2300/1827: using resistive heater
- B01L 2400/043: magnetic forces
- B01L 2400/0487: fluid pressure, pneumatics
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present disclosure is directed to systems, devices and methods for nucleic acid or protein purification and imaging. A system is provided including a cartridge comprising a sample input area configured to hold a sample, comprising a plurality of hybridized complexes comprising a plurality of target molecules each hybridized with probes and a plurality of non-hybridized probes. The cartridge may also include a first binding chamber configured with first magnetic beads to receive and bind the sample, a first elution channel configured to receive the first magnetic beads and elute the sample from the first magnetic beads, a second binding chamber configured with second magnetic beads to receive and bind the sample, a second elution channel configured to receive the second magnetic beads and elute the sample from the second magnetic beads, and a binding area configured to receive the eluted sample and hold molecules for imaging.

## Claims

### Claim 1

A cartridge configured for purifying a hybridized target molecule sample and imaging a hybridized target molecule, comprising:
a sample input area configured to hold a target molecule sample, the sample comprising:
a plurality of hybridized complexes comprising a plurality of target molecules each hybridized with a first probe and a second probe,
a plurality of non-hybridized first probes, and
a plurality of non-hybridized second probes;
a first binding chamber configured to receive and/or contain a first affinity matrix and to receive the sample, wherein:
the first affinity matrix is functionalized with first molecules configured to bind with the non-hybridized first probes and hybridized complexes of the sample during a first period of time;
the first binding chamber is additionally configured to receive a first buffer to remove non-hybridized second probes from the sample after the non-hybridized first probes and hybridized complexes of the sample bind with the first affinity matrix;
a first elution channel configured to receive the first affinity matrix after the first period of time and configured for heating the first affinity matrix to elute a first eluted sample comprising the plurality of hybridized complexes and plurality of non-hybridized first probes;
a second binding chamber configured to receive and/or contain a second affinity matrix and to receive the first eluted sample, wherein:
the second affinity matrix is functionalized with second molecules configured to bind with the hybridized complexes during a second period of time;
the second binding chamber is additionally configured to receive a second buffer to remove at least non-hybridized first probes;
a second elution channel configured to receive the second affinity matrix after the second period of time and configured for heating the second affinity matrix to elute a second eluted sample comprising the plurality of hybridized complexes; and
a binding area having an active binding surface configured to receive the second eluted sample and bind with the hybridized complexes.

### Claim 2 (depends on 1)

The cartridge of claim 1, wherein the target molecule is a nucleic acid or a protein.

### Claim 3 (depends on 1)

The cartridge of claim 1, wherein the first affinity matrix and the second affinity matrix correspond to a first set of magnetic beads and a second set of magnetic beads, respectively.

### Claim 4 (depends on 1)

The cartridge of claim 1, wherein the active binding surface comprises one of streptavidin, an avidin, and oligonucleotides.

### Claim 5 (depends on 3)

The cartridge of claim 3, wherein the cartridge further comprises:
a plurality of buffer input areas,
a plurality of first binding chambers,
a plurality of waste output areas, and
a plurality of bead pads.

### Claim 6 (depends on 1)

The cartridge of claim 1, wherein the first probes include capture probes.

### Claim 7 (depends on 1)

The cartridge of claim 1, wherein the second probes include reporter probes.

### Claim 8 (depends on 5)

The cartridge of claim 5, wherein the bubble vent configured to separate the sample input and the first binding chamber and to eliminate air bubbles

### Claim 9 (depends on 3)

The cartridge of claim 3, wherein the first magnetic beads include oligonucleotide-coupled magnetic beads.

### Claim 10 (depends on 9)

The cartridge of claim 9, wherein the oligonucleotide-coupled magnetic beads include F magnetic beads.

### Claim 11 (depends on 3)

The cartridge of claim 3, wherein the second magnetic beads include oligonucleotide-coupled magnetic beads.

### Claim 12 (depends on 11)

The cartridge of claim 11, wherein the oligonucleotide-coupled magnetic beads include G magnetic beads.

### Claim 13 (depends on 1)

The cartridge of claim 1, the cartridge being operatively coupled to:
a plurality of off-card buffer input valves operatively coupled to a fluidic manifold; and
a plurality of waste valves.

### Claim 14 (depends on 1)

The cartridge of claim 1, the cartridge further comprising:
a plurality of on-card buffer input valves operatively coupled to a fluidic manifold.

### Claim 15 (depends on 13)

The cartridge of claim 13, wherein the plurality of off-card buffer input valves are configured to receive the first buffer and the second buffer from the fluidic manifold and provide the buffer to the cartridge.

### Claim 16 (depends on 1)

The cartridge of claim 1, wherein the flow of the second eluted sample onto the binding area is done in small steps that are re-ordered based on pressure profiles.

### Claim 17 (depends on 1)

The cartridge of claim 1, wherein the binding area is further configured to receive a solution formulated to immobilize the second eluted sample on the active binding surface after stretching with flow.

### Claim 18 (depends on 17)

The cartridge of claim 17, wherein the solution includes G-hooks, anti-fade media, and fiducials.

### Claim 19

A cartridge configured for purifying a hybridized target molecule sample and imaging the hybridized target molecule, comprising:
a buffer input area configured to hold a target molecule sample, the sample comprising:
a plurality of hybridized complexes including a plurality of target molecules, and each of reporter probes and capture probes,
a plurality of non-hybridized reporter probes, and
a plurality of non-hybridized capture probes;
a bubble vent configured to separate the sample input and the first binding chamber and to eliminate air bubbles;
a first binding chamber configured to receive and/or contain F magnetic beads and to receive the sample, wherein:
the F magnetic beads are functionalized with first molecules configured to bind with the non-hybridized reporter probes and hybridized complexes of the sample during a first period of time;
the first binding chamber is additionally configured to receive a first buffer to remove non-hybridized reporter probes from the sample after the non-hybridized reporter probes and hybridized complexes of the sample bind with the F magnetic beads;
a first elution channel configured to receive the F magnetic beads after the first period of time and configured for heating the F magnetic beads to elute a first eluted sample comprising the plurality of hybridized complexes and plurality of non-hybridized reporter probes;
a second binding chamber configured to receive and/or contain G magnetic beads and to receive the first eluted sample, wherein:
the G magnetic beads are functionalized with second molecules configured to bind with the hybridized complexes during a second period of time;
the second binding chamber is additionally configured to receive a second buffer to remove at least non-hybridized capture probes;
a second elution channel configured to receive the G magnetic beads after the second period of time and configured for heating the G magnetic beads to elute a second eluted sample comprising the plurality of hybridized complexes;
a binding area having an active binding surface configured to receive the second eluted sample and bind with the hybridized complexes;
wherein the cartridge is operatively coupled to:
a plurality of off-card buffer input valves operatively coupled to a fluidic manifold, the plurality of off-card buffer input valves being configured to receive the first buffer and the second buffer from the fluidic manifold and provide the first and buffer to the cartridge; and
a plurality of waste valves configured to collect the first and second buffer from the cartridge.

### Claim 20 (depends on 19)

The cartridge of claim 19, wherein the target molecule is one of a nucleic acid or a protein.

### Claim 21 (depends on 19)

The cartridge of claim 19, wherein the active binding surface comprises one of streptavidin, an avidin, and oligonucleotides.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A system for imaging a plurality of hybridized complexes comprising;
a cartridge according to any of claims 1-16;
a cartridge tray operatively coupled to the system and configured to hold the cartridge;
a first heater operatively coupled to the cartridge;
a second heater operatively coupled to the cartridge;
a magnet operatively coupled to the imaging device below the cartridge tray;
a fluidic manifold operatively coupled to the system above the cartridge tray and configured to hold and control the flow of a plurality of buffers;
a plurality of off-card buffer input valves operatively coupled to the fluidic manifold and the cartridge;
a plurality of waste valves operatively coupled to the system above the cartridge tray; and
an imaging reference surface operatively coupled to the imaging device above the cartridge tray.

### Claim 23 (depends on 22)

The system of claim 22, wherein the first heater is configured to heat the first elution channel.

### Claim 24 (depends on 22)

The system of claim 22, wherein the second heater is configured to heat the second elution channel.

### Claim 25 (depends on 22)

The system of claim 22, wherein the magnet is configured to move the first magnetic beads and the second magnetic beads within the first and second binding chambers and the first and second elution channels.

### Claim 26 (depends on 22)

The system of claim 22, wherein the magnet is configured to move parallel to the cartridge tray.

### Claim 27 (depends on 22)

The system of claim 22, wherein the plurality of off-card buffer input valves are configured to receive the plurality of buffers from the fluidic manifold and provide the plurality of buffers to the cartridge.

### Claim 28 (depends on 22)

The system of claim 22, wherein the plurality of waste valves are configured to collect the plurality of buffers from the cartridge.

### Claim 29 (depends on 22)

The system of claim 22, further comprising:
a cam contact pad operatively coupled to the imaging device and configured to allow preloading against at least one contact pad;
at least one adjustable contact between a moving clamp and a base of the imaging device, the at least one adjustable contact configured to allow for datum A adjustment; and
a clamp motor operatively coupled to the imaging device and configured to move the moving clamp.

### Claim 30 (depends on 22)

The system of claim 22, wherein at least one of the plurality of off-card buffer input valves and the plurality of waste valves operatively coupled to the system above the cartridge tray are pneumatically controlled.

### Claim 31

A method for purifying a hybridized target molecule sample and imaging the hybridized target molecule, comprising:
receiving a hybridized sample, the sample comprising a plurality of hybridized complexes comprising target molecules hybridized with first probes and second probes, a plurality of non-hybridized first probes, and a plurality of non-hybridized second probes;
binding the non-hybridized first probes and hybridized complexes of the sample to a first affinity matrix during a first period of time to produce a first mixture;
flowing a first buffer through the first mixture to remove non-hybridized second probes from the first mixture after the non-hybridized first probes and hybridized complexes of the sample bind with the first affinity matrix;
heating the first mixture to free the non-hybridized first probes and hybridized complexes from the first affinity matrix and elute a first eluted sample comprising the plurality of hybridized complexes and plurality of non-hybridized first probes;
binding the hybridized complexes of the first eluted sample to a second affinity matrix during a second period of time to produce a second mixture;
flowing a second buffer through the second mixture to remove the non-hybridized first probes from the first eluted sample after the hybridized complexes bind with the second affinity matrix;
heating the second mixture to free the hybridized complexes from the second affinity matrix to elute a second eluted sample comprising the plurality of hybridized complexes; and
binding the hybridized complexes to an active binding surface for imaging thereof.

### Claim 32 (depends on 31)

The method of claim 31, wherein the target molecule is one of a nucleic acid or a protein.

### Claim 33 (depends on 31)

The method of claim 31, wherein the first affinity matrix and the second affinity matrix correspond to a first set of magnetic beads and a second set of magnetic beads, respectively.

### Claim 34 (depends on 31)

The method of claim 31, wherein the active binding surface comprises one of streptavidin, an avidin, and oligonucleotides.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A method for purifying a hybridized target molecule sample and imaging the hybridized target molecule, comprising:
providing the cartridge of any of claims 1-16;
receiving a hybridized sample, the sample comprising a plurality of hybridized complexes comprising target molecules hybridized with first probes and second probes, a plurality of non-hybridized first probes, and a plurality of non-hybridized second probes;
binding the non-hybridized first probes and hybridized complexes of the sample to a first affinity matrix in a first binding chamber during a first period of time;
flowing a first buffer into the first binding chamber to remove non-hybridized second probes from the sample after the non-hybridized first probes and hybridized complexes of the sample bind with the first affinity matrix;
directing the first affinity matrix into a first elution channel;
heating the first affinity matrix to elute a first eluted sample comprising the plurality of hybridized complexes and plurality of non-hybridized first probes;
binding the hybridized complexes of the first eluted sample to a second affinity matrix in a second binding chamber during a second period of time;
flowing a second buffer into the second binding chamber to remove the non-hybridized first probes from the first eluted sample after the hybridized complexes bind with the second affinity matrix;
heating the second affinity matrix to elute a second eluted sample comprising the plurality of hybridized complexes; and
binding the hybridized complexes to an active binding surface for imaging thereof.

### Claim 36 (depends on 35)

The cartridge of claim 35, wherein the target molecule is one of a nucleic acid or a protein.

### Claim 37 (depends on 35)

The cartridge of claim 35, wherein the first affinity matrix and the second affinity matrix correspond to a first set of magnetic beads and a second set of magnetic beads, respectively.

### Claim 38 (depends on 35)

The cartridge of claim 35, wherein the active binding surface comprises one of streptavidin, an avidin, and oligonucleotides.

### Claim 39 (depends on 35)

The method of claim 35, wherein the first probes include reporter probes.

### Claim 40 (depends on 35)

The method of claim 35, wherein the second probes include capture probes.

### Claim 41 (depends on 37)

The method of claim 37, wherein the first magnetic beads include F magnetic beads.

### Claim 42 (depends on 37)

The method of claim 37, wherein the second magnetic beads include G magnetic beads.

### Claim 43 (depends on 35)

The method of claim 35, wherein the first binding chamber is an F binding chamber.

### Claim 44 (depends on 35)

The method of claim 35, wherein the first period of time is a period of about 8 minutes.

### Claim 45 (depends on 35)

The method of claim 35, wherein the first magnetic beads are heated to about 47° C. for about 7 minutes.

### Claim 46 (depends on 35)

The method of claim 35, wherein the second binding chamber is a G binding chamber.

### Claim 47 (depends on 35)

The method of claim 35, wherein the second buffer is F-elution fluid.

### Claim 48 (depends on 35)

The method of claim 35, wherein the second period of time is a period of about 7 minutes.

### Claim 49 (depends on 35)

The method of claim 35, wherein the second buffer is added to the second binding chamber in increments of 24, forward and 1 μL backward.

### Claim 50 (depends on 35)

The method of claim 35, wherein the second buffer is added in increments of about +2.8 μL, +2 μL, −1 μL, +2 μL, −1 μL, +1.5 μL, and 7 μL.

### Claim 51 (depends on 35)

The method of claim 35, wherein the second magnetic beads are heated to about 47° C. for about 7 minutes.

### Claim 52 (depends on 35)

The method of claim 35, further comprising:
moving a quantity of the first eluted sample across an affinity matrix pad in a first direction and a second direction.

### Claim 53 (depends on 35)

The method of claim 35, wherein the first buffer is pumped to move sample-bead mixture through the first bead pad in a first direction and a second direction.

### Claim 54 (depends on 35)

The method of claim 35, wherein the first buffer is added in increments of approximately +15 μL, and −15 μL.
